Life-Saving Innovation on the Front Lines: FDA Licenses Ezplaz Freeze-Dried Plasma

In emergency medicine, every second counts—especially when severe blood loss is involved. On July 29, 2026, the U.S. Food and Drug Administration (FDA) made history by licensing Ezplaz Freeze Dried Plasma (FDP). Developed by Vascular Solutions, LLC (a subsidiary of Teleflex), Ezplaz is the very first freeze-dried plasma product approved for use in the United States.

By transforming liquid plasma into a room-temperature-stable powder that can be reconstituted in about a minute, Ezplaz provides a critical lifesaver in emergency situations where traditional frozen plasma simply cannot go.

The Cold Reality of Traditional Plasma

Plasma—the liquid portion of blood—contains essential proteins and clotting factors needed to stop uncontrolled bleeding. In trauma care, getting plasma into a patient quickly can mean the difference between life and death.

However, standard fresh frozen plasma comes with major logistical challenges:

• Freezing Requirements: It must be kept frozen at ultra-low temperatures, requiring heavy specialized freezers and reliable electrical power.
• Thawing Delays: Before doctors can use it, frozen plasma must be carefully thawed—a process that takes 30 to 45 minutes that trauma patients often don't have.
• Fragile Packaging: Standard plasma is traditionally stored in glass bottles or delicate containers that risk shattering during transport over rough terrain.

Because of these limits, carrying plasma on rural ambulances, air rescue helicopters, military combat missions, or disaster response vehicles has long been nearly impossible.

How Ezplaz Works in the Field

Ezplaz solves these logistical bottlenecks through lyophilization—a specialized freeze-drying process that removes moisture from plasma while preserving its delicate clotting proteins.

Derived from individual human blood donations at FDA-licensed centers, Ezplaz turns liquid plasma into a shelf-stable powder sealed in a durable, flexible plastic pouch.

A Complete All-in-One Emergency Kit

Each Ezplaz package arrives as a self-contained kit built for rapid deployment in high-stress environments. Every kit includes:

• One foil-sealed pouch of freeze-dried plasma.
• One 250 mL bag of sterile water for injection.
• One sterile fluid transfer set for rapid mixing.
• One sterile blood transfusion set for immediate delivery to the patient.

When mixed with the included sterile water, the powder dissolves in approximately 60 seconds at room temperature—no heat sources, freezers, or electrical equipment required.

Designed for Emergency Universal Use

During a crisis in a remote location, healthcare providers rarely have time to test a patient's blood type before starting a transfusion. To overcome this, Ezplaz is manufactured using Group AB blood and Group A blood with low-titer anti-B antibodies.

These specific blood types carry a low risk of adverse immune reactions, allowing first responders and military medics to administer the plasma immediately without waiting for lab compatibility testing.

Where Ezplaz Will Save Lives

While major trauma hospitals will continue using standard frozen plasma, Ezplaz fills a vital gap for remote care, including:

• Combat Zones: Providing military medics with lightweight, break-resistant plasma that fits directly into field packs.
• Disaster Response: Enabling relief teams to administer plasma in regions where power grids and medical infrastructure have failed.
• Rural Communities: Equipping rural paramedics and small community clinics with life-saving transfusion tools far from major blood banks.
• Severe Trauma & Warfarin Reversal: Treating patients with massive bleeding or those experiencing bleeding complications while taking blood-thinning medications.

A Milestone Years in the Making

Ezplaz was expedited through a close collaboration between the Department of Defense and the FDA under public legislation passed in 2017 to bring combat-ready medical technology to frontline personnel. Following extensive safety and efficacy testing showing performance equivalent to standard frozen plasma, this milestone clearance ensures that world-class trauma care is no longer tethered to a hospital freezer.

Sources & References

1. U.S. Food and Drug Administration (FDA) Press Release (July 29, 2026): "FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S."
2. PatientCare Online / Teleflex Media Release (July 29, 2026): "Ezplaz Freeze-Dried Plasma Receives First Ever FDA License in the US."
3. Respiratory Therapy (RT) Magazine (July 29, 2026): "FDA Licenses First Freeze-dried Emergency Plasma for Austere Environments."